Anupma Roy

Anupma Roy has a strong background in the pharmaceutical industry. Anupma recently served as the Director of Clinical Operations at Corcept Therapeutics, where they have been employed since 2018. Prior to that, they worked as a Senior Clinical Trial Manager at Ultragenyx Pharmaceutical Inc. from 2016 to 2018. Anupma also gained experience at Gilead Sciences as a Clinical Trials Manager from 2011 to 2016, and as an Associate Scientist from 2007 to 2011. Anupma has also held positions at Telik Inc. as a Senior Research Associate from 2004 to 2007, and at Gilead Sciences as a Senior Research Associate from 2002 to 2004. Anupma started their career as a Research Associate at Geron from 2001 to 2002.

Anupma Roy has a Master of Science (MS) degree in Molecular Biology and Genetics, which they obtained from San Jose State University. Anupma also has a Certification in Clinical Trial Management from the University of California, Santa Cruz. In addition, they hold a Clinical Trial Management Certification from UC Berkeley, although the exact date of obtaining this certification is not provided.